retatrutide to tirzepatide Weight Loss Blog – Maryland Trim Clinic Semaglutide vs. Tirzepatide vs. Retatrutide

Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) still in phase 3 trials, whilst tesamorelin is a synthetic GHRH analogue licensed only for HIV-associated lipodystrophy in the US

a systematic review and meta-analysis: do the benefits outweigh the risks

Fiber-rich foods like leafy greens, berries, whole grains, and legumes should be a part of every meal

The study found that the average weight decreased by 10.05 kg after 3 months of treatment (40)

Q: Is Foundayo safe during pregnancy

524,525 Pancreatic cancer Researchers first compared the expression of GLP-1R in human pancreatic cancer tissues with adjacent non-tumorous pancreatic tissues, finding generally lower or absent expression of GLP-1R in pancreatic cancer tissues